fda
Oleandrin Not to be Used as a Dietary Supplement Says FDA
On Sept. 4, the U.S. Food and Drug Administration (FDA) rejected an application to market Oleandrin as a dietary supplement, weeks after MyPillow CEO Mike Lindell promoted the extract as a potential treatment for the coronavirus to President Donald Trump and White House officials, according to Forbes. The FDA concluded that Oleandrin cannot legally be considered ...
Dr. Bronner’s Launches Campaign in Support of Psychedelic-Assisted Therapy
California-based Dr. Bronner’s, family-owned maker of a natural brand of soap in North America, has launched its Heal Soul campaign to support public education efforts, advocacy organizations, and political campaigns around the country working to mainstream psychedelic-assisted therapy and medicines to treat depression, PTSD, addiction and end-of-life anxiety. The company has donated over $3 million ...
New Hampshire Joins List of States to Propose CBD Regs
As the U.S. Food and Drug Administration (FDA) continues to defy mounting requests from the U.S. Congress and the natural products industry to provide science-based and public health regulations for CBD, more states are rushing in to fill the vacuum, according to the Natural Products Association (NPA). New Hampshire recently joined Virginia, Texas and Hawaii ...
Infinity Superfoods Voluntarily Discontinues Social Media and Blog Post for Infinity-C
Following an inquiry by the National Advertising Division (NAD) of BBB National Programs, California-based Infinity Superfoods discontinued a social media post and related blog posts for its Infinity-C dietary supplement. Through its routine monitoring program, NAD challenged Infinity Superfoods’ social media post for Infinity-C including an image with the text: • “The Link Between Vitamin C and the Coronavirus” and associated ...
Dietary Supplement Usage Up Dramatically During Pandemic, New Ipsos-CRN Survey Shows
The Council for Responsible Nutrition (CRN) has issued results of a COVID-19-focused consumer survey that discovered more than two in five (43 percent) of dietary supplement users have changed their supplement routines since the start of the pandemic. Among those who altered their regimens due to COVID-19, 91 percent report increasing their supplement intake which ...
NPA Proposes Streamlined Data Sharing at FDA
The Natural Products Association (NPA) outlined a streamlined process to facilitate data sharing within the agency in comments to the U.S. Food and Drug Administration (FDA). Specifically, NPA suggested sharing data from the Office of Dietary Supplement Programs on structure/function claim notifications, new dietary ingredient (NDI) notifications, current good manufacturing practice (GMP) inspections and certificate ...
FDA Submits CBD Enforcement Guidance to White House For Review
U.S. Food and Drug Administration (FDA) has submitted draft CBD (cannabidiol) enforcement guidance to the White House Office of Management and Budget (OMB) for review, according to Marijuana Moment. The contents or even basic scope of the document titled, “Cannabidiol Enforcement Policy; Draft Guidance for Industry,” are not yet publicly known. The agency was mandated ...
NPA Asks FDA to Stop Fraudulent Products from Entering U.S.
The Natural Products Association (NPA) urged the Food and Drug Administration (FDA) to do more to stop fraudulent products from entering the U.S., including issuing import alerts for nutritional supplements that fail to comply with New Dietary Ingredient (NDI) regulations. NPA submitted its comments to the FDA regarding “Food Standards; General Principles and Food Standards Modernization.” ...
Hawaii Becomes Third State to Propose CBD Regulations
As the Food and Drug Administration (FDA) continues to defy mounting requests from the U.S. Congress and the natural products industry to provide science-based and public health regulations for CBD, more states are rushing in to fill the vacuum. The State of Hawaii recently joined Virginia and Texas in proposing new state regulations for consumable hemp ...
FDA’s CBD Report to Congress Underscores Need for Regulations
While the U.S. Food and Drug Administration (FDA) has been tasked with regulating the cannabidiol (CBD) industry, the agency has repeatedly asserted it will not do so until it receives sufficient data on the cannabinoid’s safety for consumers. Yet, according to HempGrower, the agency’s latest report to Congress on July 8 evaluating the CBD marketplace underscores ...
Don't Miss Out!
Industry Professionals
Stay Informed!
Stay informed about the latest health, nutrition, and wellness developments by signing up for a FREE subscription to Vitamin Retailer magazine and digital newsletter.
Once subscribed, you will receive industry insights, product trends, and important news directly to your doorstep and inbox.
Featured Listing:
Subscribe To Our Newsletter
Stay Informed! Breaking news, industry trends featured topics, and more.
Subscribe to our newsletter today!